Skip to main content
. 2021 Aug 7;9(2):347–364. doi: 10.1007/s40487-021-00167-z

Table 4.

High-risk features for patients with newly diagnosed ovarian cancer

Inoperable FIGO stage III disease
Suboptimally debulked (> 1 cm) stage III disease
Stage IV disease

Receipt of neoadjuvant chemotherapy

Partial response to first-line platinum-based chemotherapy

FIGO International Federation of Gynecology and Obstetrics